When Pharmacies Want to Treat Patients: Germany’s Family Doctor Crisis Takes a New Twist

A simmering turf war between Germany’s doctors and pharmacists is adding a political dimension to a primary-care shortage that already sees more than 5,000 family-practice slots sitting vacant nationwide. In June, the medical profession rallied against plans by pharmacy associations to let drugstores take on tasks historically reserved for physicians—preventive check-ups, acute-care consultations, and initial dispensing of certain medicines. Doctor representatives argue that without diagnostic equipment, pharmacies cannot safely replace a trained clinician, and they warn the move jeopardises patient safety.

The conflict erupts against a backdrop of accelerating upheaval in the outpatient sector. Private-equity firms have acquired hundreds of practices in Bavaria alone, with the trend now reaching rural regions and classic family-doctor offices, according to analyses from early June. Behind the investor hunger lies a fundamental supply gap: roughly a quarter of currently practising family doctors plan to retire within the next five years, creating a wave of vacancies that alternative ownership models are rushing to fill.

Political Headwinds and a Giant Savings Target

The willingness of younger doctors or nurse practitioners to take over those practices is heavily influenced by Berlin’s regulatory climate. A draft law aimed at stabilising statutory health-insurance (GKV) contributions has provoked alarm. The German Association of Family Doctors calls the proposed GKV cost-cutting legislation an existential threat to primary care. The reform seeks to relieve the statutory insurance system by about €16.3 billion in 2027, with cuts worth billions anticipated in the physician-services segment alone.

A survey conducted at the end of May found that 77 per cent of the population expects negative consequences for medical care if the savings plan goes through. Pharmaceutical heavyweights Boehringer Ingelheim and Eli Lilly have also pushed back, questioning future investments in Germany because of planned higher rebates. The AOK insurance association dismissed those threats, pointing to the drugmakers’ billions in profits.

Succession Strategies and Regional Experiments

While the political debate rages, practice owners are crafting their own exit paths. In Berlin-Charlottenburg, a practice is recruiting a relief assistant for October 2026 with the option to later buy into half of the practice’s billing slot. A physiotherapy clinic in Saxony-Anhalt that has operated since May 1996 offers long-term takeover prospects to its employed staff. In Feldkirch, a barrier-free health-insurance practice advertised a co-operative arrangement meant to lower entry costs for successors.

Consulting firms have responded with dedicated services covering practice valuations, tax structures, and partnership models. But the broader uncertainty caused by the savings law—and by the pharmacy-competency dispute—hangs over the market.

Pharmacy Staffing and a Revised Fee

To ease its own personnel shortages, the pharmacy sector is pushing for more flexible substitution rules. A new proposal would allow pharmaceutical-technical assistants to keep a pharmacy running temporarily under certain conditions. The union Adexa has called for urgent clarification on liability and remuneration questions.

Meanwhile, a financial fix for pharmacies has been agreed: the fixed dispensing fee will rise to €9.00 on 1 July and to €9.50 on 1 January. That adjustment, however, does little to address the core conflict over clinical roles—or to calm doctors who see their profession’s scope being hollowed out just as a fifth of their colleagues prepare to walk away.

en | boerse | 69494513 |